|
Market Closed -
Nasdaq
02:30:00 07/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 79.41 USD | -5.98% |
|
-3.50% | +19.65% |
| 30/10 | DexCom Q3 Results, Higher Revenue Guidance Point to Stronger 2027, RBC Says | MT |
| 30/10 | UBS Adjusts DexCom Price Target to $107 From $102, Maintains Buy Rating | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DXCM | Delayed | |
CBOE
| DXCM | Real-time | |
|
Tradegate
| DC4 | Real-time | |
|
Boerse Muenchen
| DC4 | Real-time | |
|
Mexican S.E.
| DXCM * | End-of-day quote | |
|
Borsa Italiana
| 1DXCM | End-of-day quote | |
|
London S.E.
| 0A4M | Delayed | |
|
Deutsche Boerse AG
| DC4 | Delayed | |
|
Börse Stuttgart
| DC4 | Delayed | |
|
Xetra
| DC4 | Delayed | |
|
Wiener Boerse
| DXCM | End-of-day quote | |
|
Swiss Exchange
| DXCM | Delayed | |
|
Swiss Exchange
| DXCM | Delayed | |
Sao Paulo
| D1EX34 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 88.48 | 92.34 | 92.34 |
| Spread/Res. | -10.25% | -14.00% | -14.00% |
| Spread/Supp. | +1.89% | +12.67% | +5.36% |
| Support | 77.94 | 70.48 | 75.37 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DXCM Stock
- Charts DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
